OptiNose, Inc.
March 20, 2025 - by Joey Ramson
Shares of $OPTN are up after the company announced they were being acquired by privately held Paratek Pharmaceuticals in a deal worth up to $330 million, and will pay an initial $9 a share in cash for OptiNose, which is a 50% premium to Wednesday’s closing price of $6
